166 related articles for article (PubMed ID: 31972722)
1. Impact of Blood Transfusion on the Prevalence of HHpgV-1, HPgV-1, and B19V Among Iranian HCV-infected Patients With Hemophilia.
Agi E; Hojjatipour S; Namvar A; Bolhassani A
J Pediatr Hematol Oncol; 2020 May; 42(4):e213-e218. PubMed ID: 31972722
[TBL] [Abstract][Full Text] [Related]
2. First detection of human hepegivirus-1 (HHpgV-1) in Iranian patients with hemophilia.
Bijvand Y; Aghasadeghi MR; Sakhaee F; Pakzad P; Vaziri F; Saraji AA; Jamnani FR; Siadat SD; Fateh A
Sci Rep; 2018 Mar; 8(1):5036. PubMed ID: 29568043
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Viremia Frequencies of a Novel Human Pegivirus by Using Bioinformatic Screening and PCR.
Bonsall D; Gregory WF; Ip CL; Donfield S; Iles J; Ansari MA; Piazza P; Trebes A; Brown A; Frater J; Pybus OG; Goulder P; Klenerman P; Bowden R; Gomperts ED; Barnes E; Kapoor A; Sharp CP; Simmonds P
Emerg Infect Dis; 2016 Apr; 22(4):671-8. PubMed ID: 26982117
[TBL] [Abstract][Full Text] [Related]
4. Virome Analysis of Transfusion Recipients Reveals a Novel Human Virus That Shares Genomic Features with Hepaciviruses and Pegiviruses.
Kapoor A; Kumar A; Simmonds P; Bhuva N; Singh Chauhan L; Lee B; Sall AA; Jin Z; Morse SS; Shaz B; Burbelo PD; Lipkin WI
mBio; 2015 Sep; 6(5):e01466-15. PubMed ID: 26396247
[TBL] [Abstract][Full Text] [Related]
5. First Report of Prevalence of Blood-Borne Viruses (HBV, HCV, HIV, HTLV-1 and Parvovirus B19) Among Hemophilia Patients in Afghanistan.
Mousavi SH; Khairkhah N; Bahri TD; Anvar A; Saraji AA; Behnava B; Alavian SM; Namvar A
Sci Rep; 2019 May; 9(1):7259. PubMed ID: 31086199
[TBL] [Abstract][Full Text] [Related]
6. A Novel Human Pegivirus, HPgV-2 (HHpgV-1), Is Tightly Associated With Hepatitis C Virus (HCV) Infection and HCV/Human Immunodeficiency Virus Type 1 Coinfection.
Wang H; Wan Z; Xu R; Guan Y; Zhu N; Li J; Xie Z; Lu A; Zhang F; Fu Y; Tang S
Clin Infect Dis; 2018 Jan; 66(1):29-35. PubMed ID: 29020289
[TBL] [Abstract][Full Text] [Related]
7. Serological and virological markers of human parvovirus B19 infection in sera of hemophiliacs.
Grosse-Bley A; Eis-Hübinger AM; Kaiser R; Oldenburg J; Brackmann HH; Schwarz TF; Schneweis KE
Thromb Haemost; 1994 Oct; 72(4):503-7. PubMed ID: 7878623
[TBL] [Abstract][Full Text] [Related]
8. Discovery of a Novel Human Pegivirus in Blood Associated with Hepatitis C Virus Co-Infection.
Berg MG; Lee D; Coller K; Frankel M; Aronsohn A; Cheng K; Forberg K; Marcinkus M; Naccache SN; Dawson G; Brennan C; Jensen DM; Hackett J; Chiu CY
PLoS Pathog; 2015 Dec; 11(12):e1005325. PubMed ID: 26658760
[TBL] [Abstract][Full Text] [Related]
9. Parvovirus B19 antibodies in patients with haemophilia A.
Peerlinck K; Goubau P; Reybrouck R; Desmyter J; Vermylen J
Thromb Haemost; 1995 Mar; 73(3):555-6. PubMed ID: 7667846
[No Abstract] [Full Text] [Related]
10. Human pegivirus viremia in HCV/HIV co-infected patients: Direct acting antivirals exert anti-pegivirus effects.
Hlavay BA; Zhuo R; Ogando N; Charlton C; Stapleton JT; Klein MB; Power C
J Clin Virol; 2023 May; 162():105445. PubMed ID: 37043902
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of human parvovirus B19 and TT virus in a group of young haemophiliacs in South Africa.
Rubinstein R; Karabus CD; Smuts H; Kolia F; Van Rensburg EJ
Haemophilia; 2000 Mar; 6(2):93-7. PubMed ID: 10781195
[TBL] [Abstract][Full Text] [Related]
12. Frequent human parvovirus B19 DNA occurrence and high seroprevalence in haemophilic patients from a non-metropolitan blood centre, Brazil.
Slavov SN; Kashima S; Rocha-Junior MC; Oliveira LC; Silva-Pinto AC; Yamamoto AY; Covas DT
Transfus Med; 2014 Apr; 24(2):130-2. PubMed ID: 24684574
[No Abstract] [Full Text] [Related]
13. B19 parvovirus DNA in solvent/detergent-treated anti-haemophilia concentrates.
Lefrère JJ; Mariotti M; Thauvin M
Lancet; 1994 Jan; 343(8891):211-2. PubMed ID: 7904670
[TBL] [Abstract][Full Text] [Related]
14. [Blood-transmitted viral infections among haemophiliacs in Tunisia].
Langar H; Triki H; Gouider E; Bahri O; Djebbi A; Sadraoui A; Hafsia A; Hafsia R
Transfus Clin Biol; 2005 Oct; 12(4):301-5. PubMed ID: 16099190
[TBL] [Abstract][Full Text] [Related]
15. Chronic Human Pegivirus 2 without Hepatitis C Virus Co-infection.
Coller KE; Bruce V; Cassidy M; Gersch J; Frankel MB; Vallari A; Cloherty G; Hackett J; Evans JL; Page K; Dawson GJ
Emerg Infect Dis; 2020 Feb; 26(2):265-272. PubMed ID: 31961294
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of antibodies against parvovirus B19 in Norwegians with congenital coagulation factor defects treated with plasma products from small donor pools.
Rollag H; Patou G; Pattison JR; Degré M; Evensen SA; Fröland SS; Glomstein A
Scand J Infect Dis; 1991; 23(6):675-9. PubMed ID: 1815327
[TBL] [Abstract][Full Text] [Related]
17. Difference of Intrahost Dynamics of the Second Human Pegivirus and Hepatitis C Virus in HPgV-2/HCV-Coinfected Patients.
Liang Y; Hu F; Fan H; Li L; Wan Z; Wang H; Shui J; Zhou Y; Tong Y; Cai W; Tang S
Front Cell Infect Microbiol; 2021; 11():728415. PubMed ID: 34466405
[TBL] [Abstract][Full Text] [Related]
18. Genotype Distribution and Prevalence of Human Pegivirus among High-Risk Populations in Tunisia.
Ben Dhifallah I; Ayouni K; Chouiha A; Sadraoui A; Hogga N; Hammami W; Ben Yahya A; Triki H
Intervirology; 2016; 59(3):170-178. PubMed ID: 28132064
[TBL] [Abstract][Full Text] [Related]
19. Epidemiological and Clinical Characteristics of Human Hepegivirus 1 Infection in Patients With Hepatitis C.
Sridhar S; Yip CCY; Chew NFS; Wu S; Leung KH; Chan JFW; Cheng VCC; Yuen KY
Open Forum Infect Dis; 2019 Aug; 6(8):ofz329. PubMed ID: 31660385
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and association of human parvovirus B19V with hepatitis B and C viruses in Nigeria.
Opaleye OO; Fagbami AH; Lalremruata A; Kun JF
J Med Virol; 2011 Apr; 83(4):710-6. PubMed ID: 21328387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
